Assessment of tumor response, AFP response, and time to progression in the phase 3 CELESTIAL trial of cabozantinib versus placebo in advanced hepatocellular carcinoma (HCC) Meeting Abstract


Authors: Waidmann, O.; Merle, P.; Rimassa, L.; Ryoo, B. Y.; Cicin, I.; Harris, W. P.; Nemunaitis, J.; Olteanu, S.; Sarker, D.; Tan, B. R.; Van Vlierberghe, H.; Sen, S.; Love, C.; Cheng, A. L.; El-Khoueiry, A. B.; Meyer, T.; Kelley, R. K.; Abou-Alfa, G. K.
Abstract Title: Assessment of tumor response, AFP response, and time to progression in the phase 3 CELESTIAL trial of cabozantinib versus placebo in advanced hepatocellular carcinoma (HCC)
Meeting Title: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie
Journal Title: Oncology Research and Treatment
Volume: 41
Issue: Suppl. 4
Meeting Dates: 2018 Sep 28-Oct 2
Meeting Location: Vienna, Austria
ISSN: 2296-5270
Publisher: S. Karger AG  
Date Published: 2018-09-01
Start Page: 283
End Page: 284
Language: English
ACCESSION: WOS:000446816500689
PROVIDER: wos
PUBMED: 30261496
DOI: 10.1159/000492737
Notes: Meeting Abstract: P880 -- Source: Wos
Altmetric Score
MSK Authors
  1. Ghassan Abou-Alfa
    229 Abou-Alfa
Related MSK Work